Real-time enrollment status for this uncontrolled asthma clinical trial
Current Status
Active, Not Recruiting
Checked: June 2, 2026 at 4:10 AM UTC
| NCT Number | NCT06572228 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Uncontrolled Asthma |
| Phase | Clinical Trial |
| Target Enrollment | 250 participants |
| Active Locations | 54 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | May 22, 2026 (1 week ago) |
As of June 2, 2026: Clinical trial NCT06572228 is currently active_not_recruiting participants. This clinical trial study for uncontrolled asthma is not currently accepting new participants at 54 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06572228 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 54 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06572228 was last updated 1 week ago (May 22, 2026). HelloStudys verifies this status automatically.